Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China
· Delayed Price · Currency is CNY 11.49
+0.04 (0.35%)
Apr 30, 2026, 3:04 PM CST
4.78% (1Y)
| Market Cap | 4.78B |
| Revenue (ttm) | 459.02M |
| Net Income (ttm) | 33.80M |
| Shares Out | 417.60M |
| EPS (ttm) | 0.08 |
| PE Ratio | 143.13 |
| Forward PE | n/a |
| Dividend | 0.06 (0.52%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 2,403,260 |
| Average Volume | 4,296,537 |
| Open | 11.40 |
| Previous Close | 11.45 |
| Day's Range | 11.40 - 11.56 |
| 52-Week Range | 10.90 - 16.95 |
| Beta | 0.75 |
| RSI | 38.88 |
| Earnings Date | Mar 31, 2026 |